“What was known to C at the times of entering into the ICA and the further Transaction Documents and Attachments, or (if later) in the period before21 September 2019 , concerning: (i) the existence of D1; (ii) the nature of D1's work; (iii) the relationship between D1 and D2; and/or (iv) the activities of the Ds forming the subject matter of the RRAPOC?” ii) Issue 17: “Who made the Audit Request dated3 December 2020 and for what purpose(s) was such Audit Request made?” iii) Issue 19: “For what reason did C decide to terminate the ICA?” iv) Issue 21: “(i) When and to what extent was IBM and IBM UK aware of the SDM? (ii) Did IBM and IBM UK make statements to third parties in the marketplace, whether orally or in writing, in relation to the SDM?”
“(1) Written records of communications from1 January 2020 onwards (including emails or other electronic communications, letters, call logs or notes, and meeting minutes or notes) within IBM UK, and between (i) IBM UK and any IBM group companies (including any representative or member responsible for IBM mainframe z/OS software sales, including Mark Anzani, Paul Knight, Tom Rosamilia and/or Ray Jones (and/or his successor)) and (ii) IBM UK and RSM Partners Limited, which relate to any acts of actual or suspected non- compliance with the ICA by Winsopia or proposals to terminate the ICA. (2) Written records of investigations from1 January 2020 onwards into, or internal updates or reports of, alleged non- compliance by D2 with the ICA.”
“(2) Written records of communications (including as above) from1 March 2016 onwards recording/relating to discussions between C and any third party in the marketplace concerning (i) LzLabs, (ii) the SDM, (iii) Winsopia or (iv) the IBM-Winsopia Agreements. (3) Internal C or IBM presentations, briefings and strategy documents (including notes or summaries of the same) concerning (i) LzLabs, (ii) the SDM, (iii) Winsopia or (iv) the IBM-Winsopia Agreements, since5 November 2014 . (4) Minutes of any meetings within IBM UK and between IBM UK and other IBM group companies, from March 2016 onwards, in which IBM’s or IBM UK’s commercial strategy in relation to (i) LzLabs, (ii) the SDM or (iii) Winsopia, is recorded as having been discussed.”
“17.1 Where there has been or may have been a failure adequately to comply with an order for Extended Disclosure the court may make such further orders as may be appropriate, including an order requiring a party to – (1) serve a further, or revised, Disclosure Certificate; (2) undertake further steps, including further or more extended searches, to ensure compliance with an order for Extended Disclosure; (3) provide a further or improved Extended Disclosure List of Documents; (4) produce documents; or (5) make a witness statement explaining any matter relating to disclosure.”
“18.1 The court may at any stage make an order that varies an order for Extended Disclosure. This includes making an additional order for disclosure of specific documents or narrow classes of documents relating to a particular Issue for Disclosure. 18.2 The party applying for an order under paragraph 18.1 must satisfy the court that varying the original order for Extended Disclosure is necessary for the just disposal of the proceedings and is reasonable and proportionate …”
“The difference between these two provisions is easy to see: i)CPR 51 PD U §17 deals with the case where an Extended Disclosure order has not, or may not have been, adequately complied with. Because of the question of non-compliance, the test that must be met for the granting of an order underCPR 51 PD U §17 is that the order be "appropriate", which requires the applicant to satisfy the court that making an order is "reasonable and proportionate". ii) By contrast,CPR 51 PD U §18 deals with the case where – even though there has been compliance with an order for Extended Disclosure – the order previously made is sought to be varied. In such a case, the applicant must show not merely that making the order is "reasonable and proportionate", but also that varying the original order "is necessary for the just disposal of the proceedings". Unsurprisingly, it is harder to obtain an order underCPR 51 PD U §18 than underCPR 51 PD U §17.”
“within IBM UK, and between IBM UK and IBM group companies”
“What was known to C at the times of entering into the ICA and the further Transaction Documents and Attachments, or (if later) in the period before21 September 2019 , concerning: (i) the existence of D1; (ii) the nature of D1's work; (iii) the relationship between D1 and D2; and/or (iv) the activities of the Ds forming the subject matter of the RRAPOC?”
“The following date ranges shall be applied to the Claimant’s disclosure: … (b) In respect of Issue 4, the applicable date ranges shall be between: (i)15 February 2013 and15 September 2013 ; and (ii)5 November 2014 and21 September 2019 .”
“between (i)15 February 2013 and15 September 2013 ; and (ii)5 November 2014 and25 August 2020 (plus a week to capture internal discussions about the significance of the date).”
“Given the extremely limited information provided by IBM UK to date, it is unclear why the volume of disclosure is so low. One possibility is that IBM UK has asserted privilege over a wide range of documents, where privilege ought not to have been asserted. By way of example, IBM UK has disclosed only one document in respect of Issue 17 (IBM’s audit request). These documents could not be protected by litigation privilege on the basis that they would have been prepared for the [dominant] purpose of undertaking the audit pursuant to the audit right in the ICA, and not for the purposes of litigation. In its letter of4 July 2023 , IBM UK confirmed for the first time that IBM UK has applied litigation privilege from25 August 2020 on the basis that documents were created for the dominant purpose of the litigation. However, IBM UK also states that “To the extent that documents predating25 August 2020 were withheld from production for privilege, that is because another privilege applied.” [SKH1/479] IBM UK does not provide any further information, including what privilege is claimed in those documents, by whom, and under what applicable law. This raises serious concerns as to whether IBM UK has adequately complied with its disclosure obligations underPD57AD in these Proceedings by inappropriately claiming privilege where privilege ought not to apply.”
“As the Partner at Quinn Emanuel responsible for overseeing the Claimant’s disclosure of documents, I confirm that, having reviewed the documents in question with support from Ms. Vernon and the Claimant’s external counsel, I am satisfied that documents have only been withheld by the Claimant on the basis of privilege where the claim to privilege is properly justified. Taking the two specific areas of concern raised by Ms. Huts, and strictly without waiving privilege, I confirm that: Insofar as documents relating to Issue 17 (the Claimant’s audit request) were withheld from production, that is because each of the documents in question were either (i) created for the dominant purpose of giving and/or receiving legal advice, or were (ii) created for the dominant purpose of litigation which was reasonably in contemplation (namely claims by the Claimant for the Defendants’ alleged breaches of the ICA), or both. I do not accept Ms. Huts’ assertion that documents relating to the audit request could not be protected by litigation privilege. Insofar as documents pre-dating25 August 2020 were withheld for privilege, this is because each of the documents in question were (i) created for the dominant purpose of giving and/or receiving legal advice; and/or (ii) created for the dominant purpose of litigation which was reasonably in contemplation (in particular claims by IBM Corporation (“IBM Corp.”)). In each case the Claimant has assessed questions of privilege as a matter of English law, which (as the lex fori) governs questions of privilege in these proceedings.”
“Save as it relates solely to the proper preparation of witness evidence from Mr Anzani in these proceedings, the Claimant is not permitted to share information or documents obtained from or provided by the Defendants in the course of these proceedings with Mr Anzani, without obtaining prior permission from the Defendants or the Court.”